These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 26333917)

  • 1. The Optimized Fabrication of Nanobubbles as Ultrasound Contrast Agents for Tumor Imaging.
    Cai WB; Yang HL; Zhang J; Yin JK; Yang YL; Yuan LJ; Zhang L; Duan YY
    Sci Rep; 2015 Sep; 5():13725. PubMed ID: 26333917
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Optimized Fabrication of a Novel Nanobubble for Tumor Imaging.
    Zhang J; Chen Y; Deng C; Zhang L; Sun Z; Wang J; Yang Y; Lv Q; Han W; Xie M
    Front Pharmacol; 2019; 10():610. PubMed ID: 31214033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel dual-mode nanobubbles as potential targeted contrast agents for female tumors exploration.
    Yang H; Zhou T; Cai W; Yi X; Liu X; Wang Y; Zhang L; Duan Y
    Tumour Biol; 2016 Oct; 37(10):14153-14163. PubMed ID: 27539728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Experimental investigation of the penetration of ultrasound nanobubbles in a gastric cancer xenograft.
    Fan X; Wang L; Guo Y; Tong H; Li L; Ding J; Huang H
    Nanotechnology; 2013 Aug; 24(32):325102. PubMed ID: 23868030
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanobubble-Affibody: Novel ultrasound contrast agents for targeted molecular ultrasound imaging of tumor.
    Yang H; Cai W; Xu L; Lv X; Qiao Y; Li P; Wu H; Yang Y; Zhang L; Duan Y
    Biomaterials; 2015 Jan; 37():279-88. PubMed ID: 25453958
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Production and characterization of a novel long-acting Herceptin-targeted nanobubble contrast agent specific for Her-2-positive breast cancers.
    Jiang Q; Hao S; Xiao X; Yao J; Ou B; Zhao Z; Liu F; Pan X; Luo B; Zhi H
    Breast Cancer; 2016 May; 23(3):445-55. PubMed ID: 25691133
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuropeptide Y Y
    Li J; Tian Y; Shan D; Gong A; Zeng L; Ren W; Xiang L; Gerhard E; Zhao J; Yang J; Wu A
    Biomaterials; 2017 Feb; 116():106-117. PubMed ID: 27914983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CAIX aptamer-functionalized targeted nanobubbles for ultrasound molecular imaging of various tumors.
    Zhu L; Wang L; Liu Y; Xu D; Fang K; Guo Y
    Int J Nanomedicine; 2018; 13():6481-6495. PubMed ID: 30410333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of Bubble Concentration on the in Vitro and in Vivo Performance of Highly Stable Lipid Shell-Stabilized Micro- and Nanoscale Ultrasound Contrast Agents.
    Abenojar EC; Nittayacharn P; de Leon AC; Perera R; Wang Y; Bederman I; Exner AA
    Langmuir; 2019 Aug; 35(31):10192-10202. PubMed ID: 30913884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Construction of Nucleolin-Targeted Lipid Nanobubbles and Contrast-Enhanced Ultrasound Molecular Imaging in Triple-Negative Breast Cancer.
    Fang K; Wang L; Huang H; Lan M; Shen D; Dong S; Guo Y
    Pharm Res; 2020 Jul; 37(7):145. PubMed ID: 32666304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimized Anti-Prostate-Specific Membrane Antigen Single-Chain Variable Fragment-Loaded Nanobubbles as a Novel Targeted Ultrasound Contrast Agent for the Diagnosis of Prostate Cancer.
    Ding Y; Cao Q; Qian S; Chen X; Xu Y; Chen J; Shen H
    J Ultrasound Med; 2020 Apr; 39(4):761-773. PubMed ID: 31702068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Time-intensity-curve Analysis and Tumor Extravasation of Nanobubble Ultrasound Contrast Agents.
    Wu H; Abenojar EC; Perera R; De Leon AC; An T; Exner AA
    Ultrasound Med Biol; 2019 Sep; 45(9):2502-2514. PubMed ID: 31248638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nanobubble ultrasound contrast agents for enhanced delivery of thermal sensitizer to tumors undergoing radiofrequency ablation.
    Perera RH; Solorio L; Wu H; Gangolli M; Silverman E; Hernandez C; Peiris PM; Broome AM; Exner AA
    Pharm Res; 2014 Jun; 31(6):1407-17. PubMed ID: 23943542
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Perfluoropentane-filled chitosan poly-acrylic acid nanobubbles with high stability for long-term ultrasound imaging
    Gao X; Guo D; Mao X; Shan X; He X; Yu C
    Nanoscale; 2021 Mar; 13(10):5333-5343. PubMed ID: 33659972
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multifunctional nanoparticles for combining ultrasonic tumor imaging and targeted chemotherapy.
    Rapoport N; Gao Z; Kennedy A
    J Natl Cancer Inst; 2007 Jul; 99(14):1095-106. PubMed ID: 17623798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acoustic characterization and pharmacokinetic analyses of new nanobubble ultrasound contrast agents.
    Wu H; Rognin NG; Krupka TM; Solorio L; Yoshiara H; Guenette G; Sanders C; Kamiyama N; Exner AA
    Ultrasound Med Biol; 2013 Nov; 39(11):2137-46. PubMed ID: 23932272
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Construction of a Tumor-Targeting Nanobubble with Multiple Scattering Interfaces and its Enhancement of Ultrasound Imaging.
    Ma Z; Zhang Y; Zhu Y; Cui M; Liu Y; Duan YY; Fan L; Zhang L
    Int J Nanomedicine; 2024; 19():4651-4665. PubMed ID: 38799698
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ultrasound-Based Molecular Imaging of Tumors with PTPmu Biomarker-Targeted Nanobubble Contrast Agents.
    Johansen ML; Perera R; Abenojar E; Wang X; Vincent J; Exner AA; Brady-Kalnay SM
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33671448
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of fluorous lipid-based nanobubbles for efficiently containing perfluoropropane.
    Oda Y; Suzuki R; Mori T; Takahashi H; Natsugari H; Omata D; Unga J; Uruga H; Sugii M; Kawakami S; Higuchi Y; Yamashita F; Hashida M; Maruyama K
    Int J Pharm; 2015 Jun; 487(1-2):64-71. PubMed ID: 25841568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preparation of nanobubbles for ultrasound imaging and intracelluar drug delivery.
    Wang Y; Li X; Zhou Y; Huang P; Xu Y
    Int J Pharm; 2010 Jan; 384(1-2):148-53. PubMed ID: 19781609
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.